The effect of a novel foot prosthesis on biomechanical characteristics, functional capacity and lifestyle patterns of unilateral transtibial amputees living in South Africa - Trial PACTR202006792038036
Access comprehensive clinical trial information for PACTR202006792038036 through Pure Global AI's free database. This Not Applicable trial is sponsored by Ossur South Africa and is currently Completed. The study focuses on Injury, Occupational Diseases, Poisoning; Musculoskeletal Diseases; Orthopaedics.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Sponsor & Location
Ossur South Africa
Ossur
Timeline & Enrollment
Not Applicable
Jul 10, 2017
Oct 04, 2018
Summary
Currently, most individuals with transtibial (TTA) living in South Africa use a conventional solid-ankle cushioned-heel foot prosthesis. This type of prosthesis is a rudimentary prosthesis: a key disadvantage is the deviation in gait pattern away from “normal gait”. In recent years, advanced energy storage and return (ESAR) prostheses have become more readily available to individuals with TTA, and have been designed specifically to provide a “more normal gait” in the TTA population, through various mechanisms. The present study is the first study to assess the differences in biomechanical characteristics, functional capacity, perceptions of quality of life and physical activity patterns in a novel ESAR foot (Pro-Flex foot, Ossur, Iceland), the current gold standard ESAR foot (Vari-Flex foot, Ossur, Iceland) and the conventional foot in a sample of South African individuals with unilateral TTA.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202006792038036
Device Trial